Aileron Therapeutics, Inc.

Balance Sheet

DEC '22 DEC '21 DEC '20 DEC '19 DEC '18 DEC '17 DEC '16 DEC '15 DEC '14 DEC '13
Assets
Cash & Short-Term Investments 21.24 45.93 13.81 18.28 20.70 50.75 20.72 3.77 16.22 14.07
Cash Only 5.19 3.60 7.05 5.31 10.64 11.86 20.72 3.77 6.21 9.95
Short Term Investments 16.05 42.33 6.76 12.97 10.06 38.89 0 0 10.01 4.12
Accounts Receivable Net - - - - - - - - - -
Inventories - - - - - - - - - -
Other Current Assets 0.63 2.24 2.52 1.28 1.09 1.09 0.36 0.26 0.86 0.30
Total Current Assets 21.87 48.18 16.33 19.55 21.78 51.84 21.07 4.03 17.08 14.37
Property Plant & Equipment 0.11 0.28 0.02 6.36 7.29 0.15 0.11 0.35 0.58 0.95
Goodwill - - - - - - - - - -
Intangible Assets - - - - - - - - - -
Total Assets 22.01 48.48 16.34 26.47 30.31 52.69 22.02 5.94 17.73 16.11
Liabilities and Shareholders Equity
Current
ST Debt 0 0 0 0 0 0 0 0 0 0
Account Payable 1.72 1.21 1.60 1.45 1.73 1.60 1.97 0.64 0.95 1.80
Other Current Liabilities - - - - - - - - - -
Total Current Liabilities 3.38 4.51 3.96 5.84 5.37 4.89 4.07 2.55 2.11 4.27
Long-Term
LT Debt 0 0 0.22 0 5.34 0 0 0 0 0
Other Liabilities 0 0.07 0 4.59 - 0 0.01 0.03 0.05 0.32
Total Liabilities 3.38 4.58 4.18 10.43 10.71 4.89 4.08 2.58 2.16 4.59
Equity
Retained Earnings -272.79 -245.46 -219.29 -198.14 -168.49 -136.95 -114.34 -96.22 -83.34 -67.32
Total Equity 18.62 43.90 12.16 16.05 19.60 47.80 17.94 3.36 15.57 11.51
Total Liabilities & Shareholders Equity 22.01 48.48 16.34 26.47 30.31 52.69 22.02 5.94 17.73 16.11
MAR '23 DEC '22 SEP '22 JUN '22 MAR '22 DEC '21 SEP '21 JUN '21 MAR '21 DEC '20 SEP '20 JUN '20 MAR '20 DEC '19 SEP '19 JUN '19 MAR '19 DEC '18 SEP '18 JUN '18 MAR '18 DEC '17 SEP '17 JUN '17 MAR '17 DEC '15 SEP '15 JUN '15
Assets
Cash & Short-Term Investments 16.72 21.24 25.48 32.38 38.08 45.93 52.23 59.48 63.35 13.81 14.12 18.88 12.70 18.28 24.56 31.52 13.27 20.70 27.95 35.79 43.29 50.75 56.87 11.34 15.29 3.77 7.77 10.56
Cash Only 7.78 5.19 4.84 7.63 7.45 3.60 7.60 10.75 19.28 7.05 7.85 17.12 10.70 5.31 6.87 10.16 11.27 10.64 7.72 11.98 6.78 11.86 13.43 9.40 8.03 3.77 7.40 8.08
Short Term Investments 8.94 16.05 20.64 24.75 30.63 42.33 44.63 48.73 44.07 6.76 6.27 1.76 2 12.97 17.69 21.37 2 10.06 20.23 23.81 36.51 38.89 43.44 1.95 7.27 0 0.38 2.48
Accounts Receivable Net - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Inventories - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Current Assets 0.38 0.63 1.58 1.17 1.92 2.24 2.19 0.67 0.98 2.52 1.86 0.80 1 1.28 1.94 1.04 1.12 1.09 2.11 1.42 1.16 1.09 1.25 0.65 0.69 0.26 0.31 0.31
Total Current Assets 17.11 21.87 27.05 33.55 39.99 48.18 54.42 60.15 64.32 16.33 15.97 19.67 13.69 19.55 26.50 32.56 14.39 21.78 30.05 37.21 44.45 51.84 58.12 11.99 15.98 4.03 8.08 10.87
Property Plant & Equipment 0.05 0.11 0.15 0.20 0.24 0.28 0.32 0.35 0.33 0.02 5.70 5.89 6.12 6.36 6.59 6.76 6.94 7.29 6.83 4.12 0.13 0.15 0.11 0.11 0.12 0.35 0.42 0.51
Goodwill - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Intangible Assets - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Total Assets 17.16 22.01 27.23 33.77 40.26 48.48 54.77 60.53 64.67 16.34 22.24 26.13 20.37 26.47 33.95 40.19 22.40 30.31 38.13 42.58 45.83 52.69 59.04 15.11 17.16 5.94 9.80 11.38
Liabilities and Shareholders Equity
Current
ST Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Account Payable 0.46 1.72 0.94 1.74 1.02 1.21 1.03 1.02 0.56 1.60 1 0.99 1.09 1.45 2.35 1.72 0.86 1.73 2.99 1.58 1.80 1.60 1.65 2.21 1.04 0.64 0.38 0.44
Other Current Liabilities - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Total Current Liabilities 2.88 3.38 4.54 5.15 4.15 4.51 4.56 4.27 3.07 3.96 5.25 4.93 6.14 5.84 6.43 5.39 4.62 5.37 12.10 9.71 4.86 4.89 5.02 5.47 2.87 2.55 3.32 1.89
Long-Term
LT Debt 0 0 0 0 0 0 0 0 0.06 0.22 0.34 0.21 0 0 0 0 0 5.34 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0.07 0.10 0.13 0.12 0 4.20 4.33 4.46 4.59 4.71 4.82 4.93 - - - - 0 0 0 0 0.03 0 0
Total Liabilities 2.88 3.38 4.54 5.15 4.15 4.58 4.66 4.40 3.25 4.18 9.78 9.47 10.60 10.43 11.14 10.21 9.55 10.71 12.10 9.71 4.86 4.89 5.02 5.47 2.88 2.58 3.32 1.89
Equity
Retained Earnings -277.56 -272.79 -268.24 -261.87 -253.88 -245.46 -238.66 -231.95 -226.27 -219.29 -214.30 -209.27 -204.88 -198.14 -190.90 -183.15 -175.98 -168.49 -161.46 -154.03 -144.53 -136.95 -130.08 -123.82 -118.90 -96.22 -92.91 -89.71
Total Equity 14.27 18.62 22.70 28.62 36.11 43.90 50.11 56.13 61.42 12.16 12.46 16.65 9.77 16.05 22.82 29.98 12.85 19.60 26.03 32.87 40.98 47.80 54.01 9.63 14.28 3.36 6.48 9.49
Total Liabilities & Shareholders Equity 17.16 22.01 27.23 33.77 40.26 48.48 54.77 60.53 64.67 16.34 22.24 26.13 20.37 26.47 33.95 40.19 22.40 30.31 38.13 42.58 45.83 52.69 59.04 15.11 17.16 5.94 9.80 11.38
DEC '22 DEC '21 DEC '20 DEC '19 DEC '18 DEC '17
Sales 0 0 0 0 0 0
Sales Growth % - - - - - -
Cost of Goods Sold including D&A 0.17 0.12 0.16 0.15 0.22 0.13
Depreciation & Amortization 0.17 0.12 0.16 0.15 0.22 0.13
Gross Income -0.17 -0.12 -0.16 -0.15 -0.22 -0.13
Gross Income Growth % 39.67 -25.77 5.16 -28.90 68.99 -
Gross Margin % - - - - - -
SG&A Expense 27.58 0.41 20.50 29.96 31.90 23.50
EBIT -27.75 -0.53 -20.66 -30.11 -32.12 -23.63
EBIT Growth % 5144.99 -97.44 -31.39 -6.25 35.92 -
EBIT Margin % - - - - - -
Pretax Income
Net Income Available to Common
EPS (recurring)
Basic Shares Outstanding 4.54
MAR '23 DEC '22 SEP '22 JUN '22 MAR '22 DEC '21 SEP '21 JUN '21 MAR '21 DEC '20 SEP '20 JUN '20 MAR '20 DEC '19 SEP '19 JUN '19 MAR '19 DEC '18 SEP '18 JUN '18 MAR '18 DEC '17 SEP '17 JUN '17 MAR '17 DEC '15 SEP '15 JUN '15
Assets
Cash & Short-Term Investments 16.72 21.24 25.48 32.38